How do you perceive the current positioning of the Indian market? Do you envision possibilities for further upside, considering valuations have run up?
Several factors align for this valuation premium to sustain, if not expand. In such a scenario, equity market returns are expected to closely mirror the earnings growth rate, projected to be between 12 per cent and 15 per cent in 2024-25.
What potential risks do you foresee?
Beyond the challenging-to-predict geopolitical risks, the primary headwind currently is the sluggish recovery in rural consumption. It remains uncertain whether this could evolve into a bigger setback, significantly impacting the gross domestic product growth rate at this point. A slowdown in demand also has the potential to impede the capital expenditure cycle, which is gaining momentum on the private side. However, this challenge may be offset by the increasing export potential.
Additionally, there are geopolitical tailwinds in the manufacturing space, with companies exploring opportunities to establish capacity outside of China.
Do you see businesses benefiting from the expected cuts in interest rates?
Where do you anticipate returns coming from in the near term?
The valuations of private sector banks appear reasonable, with an attractive risk/reward profile from a one-year perspective. Another sector showing promise is pharmaceutical, with indications that the worst may be behind us. The pricing pressure, particularly in the US, has now alleviated.
In a period when numerous smallcap schemes have increased their exposure to largecaps, your smallcap scheme has no allocation to largecaps. What is the rationale behind this decision?
We aim to remain true-to-label. Despite having the flexibility to invest in largecaps, we have consistently adhered to this strategy. The scheme has completed five years. In July of the previous year, we imposed restrictions on lump sum investments to address deployment challenges, predating the discussions around smallcap liquidity issues.
We have observed a moderation in smallcap fund inflows in recent months. Simultaneously, investor interest is increasing in largecap and flexicap funds. Do you believe investors are making the right decisions?
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)